CD44 and prostate neoplasm: Previous studies have demonstrated that prostate tumor cells enlisted MDSCs through the release of SPP1 protein for migration [17], while scirrhous hepatocellular carcinoma cells inhibited dendritic cell function and hindered T-cell activation via the SPP1-CD44 axis [42].